Cardiac conduction disorders in young adults: clinical characteristics and genetic background of an underestimated population.
cardiac conduction disorders
pacemaker
young
Journal
Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317
Informations de publication
Date de publication:
09 Mar 2024
09 Mar 2024
Historique:
received:
09
01
2024
revised:
04
03
2024
accepted:
05
03
2024
medline:
12
3
2024
pubmed:
12
3
2024
entrez:
11
3
2024
Statut:
aheadofprint
Résumé
Cardiac conduction disorders (CCD) in patients <50 years are a rare and mostly unknown condition. We aimed to assess clinical characteristics and genetic background of patients < 50 years with CCD of unknown origin. We retrospectively review a consecutive series of patients with a diagnosis of CCD before the age of 50 referred to our Centre between January 2019 and December 2021. Patients underwent complete clinical examination and genetic evaluation. We enrolled 39 patients with a median age of 40 years (28-47 years) at the onset of symptoms. A cardiac implantable device (CIED) was implanted in 69% of the patients. In 15 out of 39 CCD index patients (38%), we found a total of 13 different gene variations (3 pathogenic, 6 likely pathogenic and 4 variants of uncertain significance), occurring mostly in three genes (SCN5A, TRPM4 and LMNA). In our cohort, genetic testing leads to the decision to implant an ICD in two patients for the increased risk of SCD. Patients with the occurrence of CCD before the age of 50 present a high rate of pathologic gene variations, occurring mostly in three genes (SCN5A, TRPM4 and LMNA). The presence of pathogenic variations may add information regarding the prognosis and lead to an individualized therapeutic approach.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiac conduction disorders (CCD) in patients <50 years are a rare and mostly unknown condition.
OBJECTIVE
OBJECTIVE
We aimed to assess clinical characteristics and genetic background of patients < 50 years with CCD of unknown origin.
METHODS
METHODS
We retrospectively review a consecutive series of patients with a diagnosis of CCD before the age of 50 referred to our Centre between January 2019 and December 2021. Patients underwent complete clinical examination and genetic evaluation.
RESULTS
RESULTS
We enrolled 39 patients with a median age of 40 years (28-47 years) at the onset of symptoms. A cardiac implantable device (CIED) was implanted in 69% of the patients. In 15 out of 39 CCD index patients (38%), we found a total of 13 different gene variations (3 pathogenic, 6 likely pathogenic and 4 variants of uncertain significance), occurring mostly in three genes (SCN5A, TRPM4 and LMNA). In our cohort, genetic testing leads to the decision to implant an ICD in two patients for the increased risk of SCD.
CONCLUSIONS
CONCLUSIONS
Patients with the occurrence of CCD before the age of 50 present a high rate of pathologic gene variations, occurring mostly in three genes (SCN5A, TRPM4 and LMNA). The presence of pathogenic variations may add information regarding the prognosis and lead to an individualized therapeutic approach.
Identifiants
pubmed: 38467355
pii: S1547-5271(24)00243-1
doi: 10.1016/j.hrthm.2024.03.008
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.